8 Dec 2023
AMGEN CANADA INC. v. REGENERON PHARMACEUTICALS, INC.
- Parties: The plaintiff was Amgen Canada Inc. The defendant was Regeneron Pharmaceuticals, Inc.
- Subject Matter: This action involved the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Dec. 8, 2023.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
